The article examines Korea drug pricing policy reform. The reform was motivated by a desire to enhance the efficiency and transparency of the dung against the backdrop of lack of public support, resistance of various interest print reform agenda-Korea ended up with a drug pricing policy in favor of interest groups, at the cost of heavier general public and fiscal burden. Our study suggests that health policy involves complex decision making, heavily affected by political, economic, and even diplomatic relationships. Without, controlling these, it is difficult to achieve the policy goal of bettering the publics welfare.